Last reviewed · How we verify
Calciferol
Calciferol is a Small molecule drug developed by Department of Medical Services Ministry of Public Health of Thailand. It is currently in Phase 1 development for Familial x-linked hypophosphatemic vitamin D refractory rickets, Glucocorticoid Induced Osteoporosis, Hyperparathyroidism Secondary to Chronic Renal Failure with Dialysis. Also known as: vitimin d2, Vitamin D, Vitamin D3.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Calciferol |
|---|---|
| Also known as | vitimin d2, Vitamin D, Vitamin D3 |
| Sponsor | Department of Medical Services Ministry of Public Health of Thailand |
| Target | Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | Phase 1 |
Approved indications
- Familial x-linked hypophosphatemic vitamin D refractory rickets
- Glucocorticoid Induced Osteoporosis
- Hyperparathyroidism Secondary to Chronic Renal Failure with Dialysis
- Hypocalcemia
- Hypogonadal Osteoporosis in Males
- Hypoparathyroidism
- Osteomalacia
- Osteoporosis
- Postmenopausal osteoporosis
- Prevention of dental caries
- Rickets
- Vitamin D Dependent Rickets
- Vitamin D deficiency
- Vitamin Deficiency Prevention
- Vitamin deficiency
Common side effects
Key clinical trials
- NCT01462058 (Phase 4)
- Vitamin D Absorbance Study - A Decentralized, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Pharmacokinetics of Vitamin D3 Absorption From Softgel Supplements Compared to Nano Liq (NA)
- Replenishing and Maintaining Vitamin D Status in Deficient Older Adults in Residential Care Facilities in Northern Ireland (NA)
- Pilot Study on the Bioactivity of Vitamin D in the Skin After Oral Supplementation (Phase 1)
- The Relationship Between Vitamin D and Thyroid Cancer (N/A)
- A Randomized Study to Evaluate the Effectiveness of Cholecalciferol Versus Ergocalciferol Following Kidney Disease Outcomes Quality Initiative (K/DOQI) Guidelines for Vitamin D Therapy in Stages 3 & 4 (Phase 3)
- Balikesir University, Faculty of Medicine (N/A)
- A Phase 2, Double-blind, Randomized, Placebo-Controlled, Daily-dose, Proof-of-concept Study of a Vitamin D Compound in Postmenopausal Women With Osteopenia (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calciferol CI brief — competitive landscape report
- Calciferol updates RSS · CI watch RSS
- Department of Medical Services Ministry of Public Health of Thailand portfolio CI
Frequently asked questions about Calciferol
What is Calciferol?
What is Calciferol used for?
Who makes Calciferol?
Is Calciferol also known as anything else?
What development phase is Calciferol in?
What does Calciferol target?
Related
- Target: All drugs targeting Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor
- Manufacturer: Department of Medical Services Ministry of Public Health of Thailand — full pipeline
- Therapeutic area: All drugs in Nephrology
- Indication: Drugs for Familial x-linked hypophosphatemic vitamin D refractory rickets
- Indication: Drugs for Glucocorticoid Induced Osteoporosis
- Indication: Drugs for Hyperparathyroidism Secondary to Chronic Renal Failure with Dialysis
- Also known as: vitimin d2, Vitamin D, Vitamin D3
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing